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Abstract
The therapeutic potential of -helical anti-microbial peptides (AH-AMP) toα
combat pathogens is fast gaining prominence. Based on recently published
open access software for characterizing -helical peptides (PAGAL), weα
elucidate a search methodology (SCALPEL) that leverages the massive
structural data pre-existing in the PDB database to obtain AH-AMPs belonging
to the host proteome. We provide  validation of SCALPEL on plantin vitro
pathogens ( ,  and Xylella fastidiosa Xanthomonas arboricola Liberibacter
) by identifying AH-AMPs that mirror the function and properties ofcrescens
cecropin B, a well-studied AH-AMP. The identified peptides include a linear
AH-AMP present within the existing structure of phosphoenolpyruvate
carboxylase (PPC20), and an AH-AMP mimicing the properties of the two α
-helices of cecropin B from chitinase (CHITI25). The minimum inhibitory
concentration of these peptides are comparable to that of cecropin B, while
anionic peptides used as control failed to show any inhibitory effect on these
pathogens. Substitute therapies in place of conventional chemotherapies using
membrane permeabilizing peptides like these might also prove effective to
target cancer cells. The use of native structures from the same organism could
possibly ensure that administration of such peptides will be better tolerated and
not elicit an adverse immune response. We suggest a similar approach to
target Ebola epitopes, enumerated using PAGAL recently, by selecting suitable
peptides from the human proteome, especially in wake of recent reports of
cationic amphiphiles inhibiting virus entry and infection.
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            Amendments from Version 1
We have modified the manuscript based on the reviewers’ 
comments, especially with respect to clarifying two aspects
a) The fact that peptides extracted from native proteins will not
elicit an immune response is a hypothesis - and needs to be 
verified.
b) The effectiveness of alpha helical peptides in combating
cancer cells is not completely proven.
We have also added three authors in this version based on their 
inputs to this work, they had been inadvertently excluded in the 
first version.
See referee reports
REVISED
Introduction
The abundance of alpha helical (AH) structures present within pro-
teins bears testimony to their relevance in determining functionality1. 
AHs are key components in protein-protein interaction interfaces2, 
DNA binding motifs3, proteins that permeate biological mem-
branes4, and anti-microbial peptides (AMP)5,6. Not surprisingly, 
these AHs are the targets for antibody binding7,8 and therapeu-
tic agents9. These therapies in turn use AH peptides against both 
viral10–12 and bacterial pathogens13.
Some AHs have unique characteristics, which are strongly corre-
lated to their significance in the function of a protein7. For example, 
hydrophobic residues aligned on one surface (characterized by a 
hydrophobic moment14), is critical for virus entry into host cells15, 
and in the permeabilizing abilities of AH-AMPs16. Often, AHs have 
cationic residues on the opposite side of the hydrophobic surface, 
which helps them target bacterial membranes17,18. We have previ-
ously implemented known methods19 of evaluating these properties, 
and provided this as open source software (PAGAL)20. PAGAL was 
used to characterize the proteome of the Ebola virus7, and to corre-
late the binding of the Ebola protein VP2421 to human karyopherin22 
with the immune suppression and pathogenicity mechanisms of 
Ebola and Marburg viruses23.
Plant pathogens, like Xylella fastidiosa (Xf)24, Xanthomonas arbo-
ricola (Xa)25 and Liberibacter crescens (Lc)26 are a source of serious 
concern for economic27 and humanitarian reasons28. Specifically, 
we have been involved in developing novel strategies to counter 
the Pierce’s disease causing Xf, having previously designed a chi-
meric protein with anti-microbial properties that provides grape-
vines with enhanced resistance against Xf29. Cecropin B (CECB) is 
the lytic component of this chimeric protein30,31. However, the non- 
nativeness of CECB raises concerns regarding its viability in practi-
cal applications32.
In an effort to replace CECB with an equivalent peptide from the 
grapevine/citrus genome, we present a design methodology to 
select AH-AMPs from any given genome - Search characteristic 
alpha helical peptides in the PDB database and locate it in the 
genome (SCALPEL). CECB consist of two AHs, joined by a small 
loop. The N-terminal AH is cationic and hydrophobic, while the 
C-terminal AH consists of primarily hydrophobic residues. Charac-
terizing all available AHs from plant proteins in the PDB database 
allowed us to identify a peptide with a large hydrophobic moment 
and a high proportion of positively charged residues, present in 
both grapevine and citrus (our organisms of interest), mirroring 
the linear cationic CECB N-terminal AH. One such match was a 
twenty residue long AH from phosphoenolpyruvate carboxylase in 
sunflower33. The sequence of this peptide was used to find homolo-
gous peptides in the grapevine and citrus genome (PPC20). Subse-
quently, we used the SCALPEL algorithm to detect two contiguous 
AHs connected with a loop, mirroring the properties of CECB in 
a chitinase (CHITI25) from Nicotiana tobaccum (PDBid:3ALG)34. 
Subsequently, we demonstrate through bioassay experiments that 
PPC20 from the grapevine and citrus genome, and CHITI25 from 
the tobacco genome, inhibit Xf, Xa and Lc growth. The minimum 
inhibitory concentration of these peptides are comparable to that of 
CECB, while anionic peptides used as controls failed to show any 
inhibitory effect with these pathogens. Further, we observed varia-
tion in the susceptibility of the pathogens to these peptides.
Materials and methods
In silico
The PDB database was queried for the keyword ‘plants’, and pro-
teins with the exact same sequences were removed. This resulted 
in a set of ~2000 proteins (see list.plants.txt in Dataset 1). These 
proteins were analyzed using DSSP35 to identify the AHs, and AHs 
with the same sequence were removed. This resulted in ~6000 AHs 
(see ALPHAHELICES.zip in Dataset 1). PAGAL was applied to 
this set of AHs (see RawDataHelix.txt in Dataset 1). This data was 
refined to obtain peptides with different characteristics. We also 
computed the set of all pairs of AHs that are connected with a short 
(less than five residues) loop (see HTH in Dataset 1). This set is 
used to extract a pair of AHs, such that one of them is cationic with 
a large hydrophobic moment, while the other comprises mostly of 
hydrophobic residues. The PAGAL algorithm has been detailed 
previously20. Briefly, the Edmundson wheel is computed by con-
sidering a wheel with centre (0,0), radius 5, first residue coordinate 
(0,5) and advancing each subsequent residue by 100 degrees on the 
circle, as 3.6 turns of the helix makes one full circle. We compute the 
hydrophobic moment by connecting the center to the coordinate of 
the residue and give it a magnitude obtained from the hydrophobic 
scale (in our case, this scale is obtained from Jones et al.19). These 
vectors are then added to obtain the final hydrophobic moment. The 
color coding for the Edmundson wheel is as follows: all hydropho-
bic residues are colored red, while hydrophilic residues are colored 
in blue: dark blue for positively charged residues, medium blue for 
negatively charged residues and light blue for amides. All protein 
structures were rendered by PyMol (http://www.pymol.org/). The 
sequence alignment was done using ClustalW36. The alignment 
images were generated using Seaview37. Protein structures have 
been superimposed using MUSTANG38.
In vitro
Synthesized chemical peptides were obtained from GenScript 
USA, Inc. The protein molecular weight was calculated per peptide 
then diluted to 2000µM or 3000µM stock solutions with phosphate 
buffered saline. Stock solutions were stored in -20°C and thawed 
on ice before use.
Using the stock solutions, we made dilute solutions of 300µM, 
250µM, 200µM, 150µM, 100µM, 75µM, 50µM, 30µM, 25µM, 
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and 10µM to a final volume of 100µl of phosphate buffered saline. 
Dilute peptide solutions were stored in -20°C and thawed on ice 
before use.
Xylella fastidosa 3A2 (PD3)39, Xanthomonas arboricola 417 
(TYS)40, and Liberibacter crescens BT-1 (BM7)41 media were pre-
pared and autoclaved at 121°C for 15–30 minutes, then cooled and 
poured into 100 × 15mm sterile petri dishes. Kanamycin (50µg/ml) 
was added to PD3.
Bacteria were inoculated and allowed to grow in liquid medium at 
28°C: Xf (5 days), Xa (3 days), and Lc (3 days) to reach the expo-
nential phase. The inoculum was diluted to a working OD of 0.5 
(1×107 cells/ml). 10µl of the OD 0.5 was plated with 90µl of liquid 
media and spread on the pre-made agar plates to create a confluent 
lawn of bacteria. The bacteria were given an hour to set at room 
temperature. 10µl of each peptide concentration was spotted onto 
a plate of agar preseeded with a layer of bacterium. After spotting 
the plates were incubated at 28°C for 2 to 10 days till zones of 
clearance were clearly visible and the plates were scored for the 
minimum inhibitory concentration (MIC) as that beyond which no 
visible clearance was observed. Data presented is in triplicate, and 
were identical.
Results
Dataset 1. Data used for SCALPEL search methodology to 
identify plant alpha helical - antimicrobial peptides in the PDB 
database
http://dx.doi.org/10.5256/f1000research.5802.d39823
list.plants.txt: list of PDB IDs resulting from querying the PDB 
database with the keyword ‘plant’. ALPHAHELICES.zip: DSSP 
analysis of proteins listed in list.plants.txt to identify alpha 
helices. RawDataHelix.txt: PAGAL analysis of alpha helices listed 
in ALPHAHELICES.zip. HTH: Set of all pairs of alpha helices 
connected with a short (<five residues) loop.
Existing AH-AMPs: the positive controls
Cecropin B (CECB) was used as a positive control, as it is known 
to target membrane surfaces and creates pores in the bacterial 
outer membrane30,31. CECB consists of an cationic amphipathic 
N-Terminal with a large hydrophobic moment (Figure 1a), and a 
C-Terminal comprising mostly of hydrophobic residues, which 
consequently has a low hydrophobic moment, (Figure 1b) joined by 
a short loop. Another positive control was a linear AH-AMP con-
sisting of the residues 2-22 of the N-Terminal in CECB (CBNT21) 
(Figure 1a). The sequences of these are shown in Table 1.
Figure 1. Edmundson wheel for AHs in the known AMPs that were used as control. The color coding for the Edmundson wheel is as 
follows: all hydrophobic residues are colored red, while hydrophilic residues are colored in blue: dark blue for positively charged residues, 
medium blue for negatively charged residues and light blue for amides. The hydrophobic moment arrow is not to scale. (a) N-terminal of 
Cecropin B (CECB) shows its amphipathic nature, with one side being cationic and the other side hydrophobic. (b) C-terminal of CECB 
consists of mostly hydrophobic residues, and thus has a low hydrophobic moment. (c) Edmundson wheel for PPC20. (d) Edmundson wheel 
for 3ALGA.α4, which corresponds to the C-terminal of CECB and comprises mostly of hydrophobic residues (low hydrophobic moment). (e) 
Edmundson wheel for 3ALGA.α5, which corresponds to the cationic, N-terminal of CECB with a large hydrophobic moment.
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SCALPEL: Identifying native AH-AMP peptides from the 
host proteome
Linear AH-AMPs. In order to choose a peptide mimicking 
CBNT21 (cationic, amphipathic, large hydrophobic moment), we 
directed our search to ‘locate a small peptide with a large hydropho-
bic moment and a high proportion of positively charged residues’ 
on the raw data computed using PAGAL (See RawDataHelix.txt in 
Dataset 1). A small peptide is essential for quick and cost effective 
iterations. Table 2 shows the best matching AHs. Next, we used the 
sequence of these AHs to search the grapevine and citrus genomes, 
choosing only those that are present in both genomes. This allowed 
us to locate an AH from phosphoenolpyruvate carboxylase from 
sunflower, a key enzyme in the C4-photosynthetic carbon cycle 
which enhances solar conversion efficiency (PDBid:3ZGBA.α11)33. 
Figure 2a shows the specific AH located within the protein structure, 
marked in green and blue. Although DSSP marks the whole peptide 
stretch as one AH, we chose the AH in blue due to the presence 
of a small π helix preceding that. We named this peptide PPC20 
(Figure 2, Table 1). This peptide is fully conserved (100% identity 
in the 20 residues) in both grapevine (Accession id:XP_002285441) 
and citrus (Accession id:AGS12489.1). Figure 2b,c shows the 
Pymol rendered AH surfaces of PPC20. The Asp259 stands out as a 
negative residue in an otherwise positive surface (Figure 2c). Since 
previous studies have noted dramatic transitions with a single muta-
tion on the polar face, it would be interesting to find the effect of 
mutating Asp259 to a cationic residue42.
Non-linear AH-AMPs consisting of two AHs. Next, we located two 
AHs within chitinase from Nicotiana tobaccum (PDBid:3ALGA.
α4 and 3ALGA.α5)34 connected by a short random coil such that 
one of the AHs is cationic and hydrophobic, while the other AH is 
comprised mostly of hydrophobic, uncharged residues (CHITI25, 
Figure 3a, Table 1). This peptide mimics the complete CECB pro-
tein (Figure 3b). While the properties of the AHs in CHITI25 is 
reversed from that of CECB, the order in which these AHs occur is 
not important for functionality. The multiple sequence alignment of 
CHITI25 from grapevine, citrus and tobacco is shown in Figure 3c. 
CHITI25 from tobacco is the most cationic (five), followed by cit-
rus (four) and grapevine (three). Thus, it is possible that the anti-
microbial properties of CHITI25 from grapevine would be lower 
Table 1. Sequences of peptides used in this study. CO: control peptides SC: SCALPEL generated 
peptides.
CO CECB KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL full length CECB from Hyalophora cecropia (silk moth)
CO CBNT21 WKVFKKIEKMGRNIRNGIVKA N-terminal CECB (minus the first lysine)
SC PPC20 TIWKGVPKFLRRVDTALKNI Linear cationic AH-AMP from phosphoenolpyruvate carboxylase (PDBid:3ZGBA)
SC CHITI25 TAYGIMARQPNSRKSFIDSSIRLAR CECB like AH-AMP from chitinase Nicotiana tobaccum (PDBid:3ALGA)
SC ISS15 TLDELELFTDAVERW Linear anionic peptide from isoprene synthase from gray poplar (PDBid:3N0FA)
Table 2. Identifying AHs with cationic properties from plant proteins with 
known structures. All AHs in plant proteins are analyzed using PAGAL, and the 
data is pruned for AHs with a high proportion of positive residues, and finally 
sorted based on their hydrophobic moment. The first match is present in both 
grapevine and citrus (PDBid:3ZGBA.α11, which is a phosphoenolpyruvate 
carboxylase from sunflower). We ignored a small π AH in the beginning of this 
peptide comprising four residues. This peptide has been named PPC20. HM: 
Hydrophobic moment, RPNR: Relative proportion of positive residues among 
charged residues, Len: length of the α, NCH: number of charged residues.
PDB.α Len HM RPNR NCH
3ZGBA.α11 (PPC20) 24 12.6 0.8 8
4HWIA.α10 17 12.3 0.9 9
4BXHB.α11 23 12.3 0.8 8
2J376.α1 18 10.5 0.9 8
3J61R.α4 21 10.4 0.9 10
3J60G.α3 44 10.2 0.8 22
1W07A.α4 21 9.9 0.8 10
2WWBM.α1 17 9.5 0.9 8
1B8GA.α17 27 7.3 0.9 11
3J61L.α1 19 7.2 1 9
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Figure 2. Peptide PPC20 from phosphoenolpyruvate carboxylase in sunflower (PDBid:3ZGBA.α11). (a) 3ZGBA.α11 is marked in green 
and blue. We ignore the π AH, and also the small AH preceding it (marked in green). PPC20 is marked in blue. (b) Hydrophobic surface of 
PPC20. (c) Charged surface of PPC20. Asp259 stands out as a negative residue in an otherwise positive surface.
??? ???
???
Figure 3. Peptide CHITI25 from chitinase in tobacco (PDBid:3ALGA). (a) PDBid:3ALGA.α4 in green, loop in magenta and 3ALGA.α5 in 
blue. (b) Superimposing CECB (PDBid:2IGRA) in red with CHITI25 in green using MUSTANG38. Note, that the order of the AHs are reversed. 
(c) Multiple sequence alignment of CHITI25 from grapevine (CHITIVit), citrus (CHITICit) and tobacco (CHITITob). CHITITob is the more 
cationic than CHITIVit or CHITICit.
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than CHITI25 from tobacco. These peptides can be subjected to 
mutations to enhance their natural anti-microbial properties in such 
a scenario43.
Negative control - an anionic AH-AMP. We also located an ani-
onic AH-AMP using a similar strategy - a 13 residue peptide present 
within the structure of isoprene synthase from gray poplar (PDBid: 
3N0FA.α18)44. We also used phosphate buffered saline as a negative 
control. We have extended this helix on both terminals by including 
one adjacent residue from both terminals to obtain ISS15 (Table 1).
In vitro results
We have validated our peptides using plating assays (Table 3, 
Figure 4). CECB, the well-established AH-AMP, is the most 
Table 3. Minimum Inhibitory Concentration of peptides tested (µM). It can be seen that CECB is the most 
efficient among all the peptides for all three pathogens, while the anionic ISS15 does not show any effect even 
at higher concentrations. However, while CHITI25 is almost as effective as CECB for Xf, it fails to inhibit Lc 
growth. Also, Xa is much more susceptible to these peptides compared to the other two pathogens. Finally, the 
anionic ISS15 has no effect on these pathogens. Data is in triplicate, and were identical.
Bacteria CECB CBNT21 PPC20 CHITI25 ISS15
γ Proteobacteria Xylella fastidiosa 3A2 (Xf) Xanthomonas arboricola 417 (Xa)
100 
25
200 
25
150 
50
100 
150
>300 
>300
α Proteobacteria Liberibacter crescens BT-1 (Lc) 100 200 200 >300 >300
Figure 4. In vitro validation of SCALPEL methodology. Plating assay to determine minimum inhibitory concentration (MIC) of SCALPEL 
identified peptides for Xanthomonas arboricola. Counter-clockwise: 300µM, 250µM, 200µM, 150µM, 100µM 75µM, 50µM, 30µM, 25µM, 10µM, 
PBS. CECB: MIC 25, CBNT2: MIC 10, PPC20: MIC 50, CHITI25: MIC 150, ISS15: MIC >300.
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potent among all the peptides tested, having minimum inhibitory 
concentrations of between 25µM (for Xa) to 100µM (for Xf and 
Lc). This shows the variations in susceptibilities of different organ-
isms. Understanding this differential susceptibility would require a 
deeper understanding of the underlying mechanism by which these 
AH-AMPs work45, as well as the difference in the membrane com-
position of these gram-negative pathogens46. Mostly, CBNT21 has 
a slightly lower potency, indicating a role for the C-terminal AH 
in CECB, which comprises of mostly hydrophobic residues for Xf 
and Lc. This results corroborates a plausible mechanism suggested 
by others in which the anionic membranes of bacteria is targeted 
by the cationic N-terminal, and followed by the insertion of the 
C-terminal AH into the hydrophobic membrane creating a pore. 
PPC20 and CHITI25 have comparable potencies with CECB and 
CBNT21, although Lc appears to be resistant to CHITI25. Finally, 
the anionic peptide used as a negative control shows no effect on 
these pathogens.
Discussion
The repertoire of defense proteins available to an organism is being 
constantly reshaped through genomic changes that confer resistance 
to pathogens. Genetic approaches aim at achieving the same goal of 
enhancing immunity through rational design of peptides13,47, which 
are then incorporated into the genome29,31,48. Also, it is important to 
ensure that these non-endogenous genomic fragments have mini-
mal effect on humans for their commercial viability32. Identifying 
peptides from the same genome helps allay these concerns to a sig-
nificant extent. The key innovation of the current work is the ability 
to identify peptides with specific properties (cationic AHs with a 
hydrophobic surface, linear or otherwise) from the genome of any 
organism of interest. Such peptides also present less likelihood of 
eliciting an adverse immune response from the host.
Alternate methods
Alternate computational methods for finding such new AMPs based 
on known AMPs could be of two kinds, although neither method 
is as effective in obtaining our results. Firstly, a sequence search 
using BLAST can be done to find a corresponding peptide in the 
genome, say for cecropin B. However, a BLAST of the cecropin 
sequence does not give any significant matches in the grapevine 
or citrus genomes, and is a dead end. In principle, what we need is 
a peptide with cecropin B like properties - and that information is 
not encoded in the linear sequence, but in the Edmundson wheel of 
the AH. The second method for such a search is to find structural 
homology in the PDB database through a tool like DALILITE49. 
However, AHs are almost indistinguishable structurally, and the 
results will give rise to many redundancies. Thus, there are no 
existing methods tailored to incorporate the quantifiable properties 
of AHs in the search. We, for the first time, have proposed such a 
method in SCALPEL.
Computer-assisted design strategies have also been applied in 
designing de novo AMPs50,51. Other hand curated comprehensive 
databases for ‘for storing, classifying, searching, predicting, and 
designing potent peptides against pathogenic bacteria, viruses, 
fungi, parasites, and cancer cells’52 do not enjoy the automation 
and vastness of available data elucidated in the SCALPEL 
methodology.
Limitations and future directions
There are several caveats to our study. We are yet to ascertain the 
hemolytic nature of the identified peptides, and will be performing 
these experiments in the near future. In fact, the selective cytotoxic-
ity against human cancer cells, might be used as a substitute therapy 
in place of conventional chemotherapy53,54. It must be noted that the 
development of a selective peptide with anti-cancer cell properties 
has been a challenge55. Although, we have not measured the lipid 
permeabilizing abilities of our peptides, a recent study has found 
that potency in permeabilizing bacteria-like lipid vesicles does not 
correlate with significant improvements in antimicrobial activity, 
rendering such measurements redundant56. The electrostatic context 
of an peptide is known to have a significant bearing on its propen-
sity to adopt an AH structure. The ability to predict the folding of 
peptides requires significant computational power and modelling 
expertise57. Peptides often remain in random coil conformations, 
and achieve helical structures only by interacting with anionic 
membrane models58. It is also possible to measure peptide helic-
ity through circular dichroism spectroscopy59. However, our results 
have been all positive based on selected choices of peptides arising 
from our search results, and suggest a high likelihood of getting 
anti-microbial activity from these peptides. Additionally, we may 
have to resort to other innovative techniques that have been previ-
ously adopted to overcome thermodynamic instability or proteo-
lytic susceptibility60–63.
Conclusion
To summarize, we establish the presence of a large number of 
AH-AMPs ‘hidden’ in the universal proteome. We have designed 
a methodology to extract such peptides from the PDB database - 
the ‘Big Data’ center in proteomics. We demonstrate our results on 
well known plant pathogens - Xf, Xa and Lc. The feasibility of using 
such peptides in cancer therapies is also strong54,64. The ability to 
choose a peptide from the host itself is an invaluable asset, since 
nativeness of the peptide allays fears of eliciting a negative immune 
response upon administration. The problem of antibiotic resistance 
is also increasing focus on peptide based therapies9,65, since it is ‘an 
enigma that bacteria have not developed highly effective cationic 
AMP-resistance mechanisms’66. Lastly, in face of the current Ebola 
outbreak67,68, we strongly suggest the possibility of developing pep-
tides derived from the human genome to target viral epitopes, such 
as those enumerated for the Ebola virus recently7. A recent study 
has reported the inhibition of the Ebola virus entry and infection by 
several cationic amphiphiles69, suggesting the SCALPEL generated 
cationic peptides with the aid of cell penetrating peptides70 could 
achieve similar results.
Data availability
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PDB database, 10.5256/f1000research.5802.d3982371
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I think this article is quite interesting and think the authors have answered prior critiques reasonable well. I
do not have much in the way of further critiques.
 
My specific critiques are as follows:
 
1. The results presented in Table 3 do not show any statistics (e.g. p values or standard error).
2. The best negative control for such studies is use of a scrambled version of peptide.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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Title:
Suggest inserting 'sequences' after anti-microbial peptide, and include 'plant' since the search was made
for plant proteins and validated on phytopathogens.
Abstract: 
The contents starting from “Substitute therapies .... end”  are hypothetical and need to be deleted or toned
down. 
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Paragraph 3. Clarify which humanitarian reasons are associated with the listed plant pathogens. The
central theme of the manuscript is a new search algorithm, SCALPEL and its validation. Therefore, there
is a need for reasoning the development of a new algorithm in light of the existing software(s), if any. In
other words, what is the necessity of a new algorithm? The introduction is not crisp and balanced. 
Materials and Methods: 
In silico: Is their a need to list all 2000 proteins in Dataset identified using search ‘plants’. Simply, it
could be stated that as many plant proteins were analyzed. Need more details for SCALPEL
vis-á-vis methodology.
In vitro: Why was Kanamycin added to PD3?
Results:
Figure 1a: An explanation is required for omitting the first ‘K’ in Edmundson wheel.
 
The main legend to Figure 1 “Edmundson wheel for AHs in the known AMPs that were used as
control” is confusing. It does not look like the peptides corresponding to wheels c, d and e were the
controls.
 
PPC20, 3ALGA.α4 and 3ALGA.α5 (Fig. 1c, d, e) should be described when first mentioned in the
text.
 
Non-linear AH-AMPs consisting of two AHs: “While the properties of the AHs in CHITI25 is
reversed from that of CECB, the order in which these AHs occur is not important for functionality” is
an overstatement unless proved.
 
Figure 4. The PBS used for peptide dilution does not appear as a control in the Figure. The control
ISS15 does not show pathogen growth inhibition at the maximum concentration tested. Thus, to
conclude its MIC is >300 microM is a speculation.
Discussion:
The discussion is entirely focused on the search software that is hardly mentioned in the Introduction,
Methodology, and Results. There is more focus on the application of the current study instead of the study
itself. The readership would benefit more if the discussion included scrutiny and reaffirmation of the
results with relevant literature and interpretation.
We have read this submission. We believe that we have an appropriate level of expertise to
confirm that it is of an acceptable scientific standard, however we have significant reservations,
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the indexing of this article.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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Title and Abstract:
The Title of the article, "The PDB database is a rich source of alpha-helical anti-microbial peptides to
combat disease causing pathogens", is appropriate for the content of the article. However because the
detected peptides were solely tested toward plant pathogens the term of "plant" in the title could be
considered. The abstract represent rather well the work presented in the article except the two last
sentences which are expectations of the authors but were not studied in this work. Particularly the
sentence : "The use of native…" assert that peptide structure extracted from native proteins will be without
adverse effect to the host but it has to be proved in my opinion.
:Article content
The paper describes the use of a software and an method developed by the authors to screen the in silico 
protein database (PDB) to find new antimicrobial peptides on the basis of the secondary structures of
these peptides. The method is innovative and very interesting. Moreover the authors proved the efficacy
of their method as they synthesized peptides from portions of protein sequences presenting secondary
structures resembling cecropin B and demonstrated the antimicrobial activity of these new peptides.
However I did not understand why they used an anionic peptide as the negative control. Indeed it is well
known that the global positive charge of the peptides is required for their initial stacking on the membrane
of target cells. Thus it is predictable that any anionic peptide will be inactive.
:Conclusions
The main problem concerns the conclusions of the article. Indeed there are not sufficient experimental
evidences in the article to assert that the alpha-helical peptides with antimicrobial activity have a strong
potency to act toward cancer cells. In my experience I tested several alpha-helical peptides which were
solely antimicrobial. Thus I strongly suggest to moderate this conclusions part of the manuscript.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
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, Tata Institute of Fundamental Research, IndiaSandeep Chakraborty
Dear Dr Berjeaud,
We would like to thank you for taking the time to review this paper. Please find our responses
below.
Title and Abstract: The Title of the article, ”The PDB database is a rich source of
alpha-helical anti-microbial peptides to combat disease causing pathogens”, is
appropriate for the content of the article. However because the detected peptides were
solely tested toward plant pathogens the term of ”plant” in the title could be considered.
We are in the process of testing these peptides on other pathogens. Furthermore, considering that
the mechanism of the inhibitory effect of these peptides is independent of the pathogen host, we
are quite confident of replicating our results on other ‘non-plant’ pathogens.
The abstract represent rather well the work presented in the article except the two last
sentences which are expectations of the authors but were not studied in this work.
Particularly the sentence : ”The use of native” assert that peptide structure extracted from
native proteins will be without adverse effect to the host but it has to be proved in my
opinion.
We believe this is an important hypothesis, although unproven, which differentiates SCALPEL from
other methods of identifying anti-microbial peptides. However, we have modified the statement in
the abstract to make this less of an assertion, and more of a hypothesis.
Article content: The paper describes the use of a software and an in silico method
developed by the authors to screen the protein database (PDB) to find new antimicrobial
peptides on the basis of the secondary structures of these peptides. The method is
innovative and very interesting. Moreover the authors proved the efficacy of their method
as they synthesized peptides from portions of protein sequences presenting secondary
structures resembling cecropin B and demonstrated the antimicrobial activity of these
new peptides.
We appreciate the positive comments.
However I did not understand why they used an anionic peptide as the negative control.
Indeed it is well known that the global positive charge of the peptides is required for their
initial stacking on the membrane of target cells. Thus it is predictable that any anionic
peptide will be inactive.
We have used this as a negative control. If our experimental setup in the process of adding the
peptides had any undesired conditions which was inhibiting the pathogens, this anionic peptide
would show positive results. So, this is slightly different from a null negative control, as it involves
adding a peptide.
Conclusions: The main problem concerns the conclusions of the article. Indeed there are
not sufficient experimental evidences in the article to assert that the alpha-helical
peptides with antimicrobial activity have a strong potency to act toward cancer cells. In
my experience I tested several alpha-helical peptides which were solely antimicrobial.
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my experience I tested several alpha-helical peptides which were solely antimicrobial.
Thus I strongly suggest to moderate this conclusions part of the manuscript.
We appreciate your concern regarding the lack of confirmatory evidence of AH peptides as
anti-cancer therapeutics. However, this continues to be an active front in research, and we hope
that SCALPEL will provide further avenues for testing this hypothesis. We have cited two recent
papers-  and http://www.ncbi.nlm.nih.gov/pubmed/25270878
http://www.ncbi.nlm.nih.gov/pubmed/24101917
in this context. Also, we have modified the text to reflect the lack of conclusiveness in such
studies.Once again, we are thankful for your insightful comments, and hope to have addressed
your concerns.
Thanking you,
Sincerely,
Sandeep Chakraborty
Plant Sciences Department,
University of California, Davis, CA 95616, USA. 
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